Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis.

Autor: Sydnor S; Novartis Pharmaceuticals UK Ltd., London, England, UK., Chatterjee S; CONEXTS, Novartis Healthcare Pvt. Ltd., Hyderabad, India., Cooney P; CONEXTS, Novartis Ireland Ltd., Dublin, Ireland., Kaur S; CONEXTS, Novartis Healthcare Pvt. Ltd., Hyderabad, India., Macmillan T; Source Health Economics, Oxford, England, UK., Stewart D; Source Health Economics, Oxford, England, UK., Munro I; Source Health Economics, London, England, UK., Bandeiras C; CONEXTS, Novartis Ireland Ltd., Dublin, Ireland., Paine A; Source Health Economics, Oxford, England, UK., Felizzi F; Novartis Pharma AG, Fabrikstrasse 2, 4056, Basel, Switzerland. federico.felizzi@novartis.com.

Publikováno v: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2023 Jul; Vol. 14 (7), pp. 1193-1216. Date of Electronic Publication: 2023 May 17.

CO40 Vision-Related Quality of Life in Patients With Diabetic Macular Edema Treated With Brolucizumab 6 Mg vs Aflibercept 2 Mg in the Kestrel and Kite Studies

Autor: Felizzi, F, Bouillaud, E, Pagadala, V, Igwe, F, Bandeiras, C, Wang, L, Kovacic, L, Wang, Y

Publikováno v: In Value in Health December 2022 25(12) Supplement:S25-S25

Comparative assessment of intrinsic mechanical stimuli on knee cartilage and compressed agarose constructs

Autor: Completo, A. ^*, Bandeiras, C., Fonseca, F.

Publikováno v: In Medical Engineering and Physics June 2017 44:87-93

PNS126 Simpli – a Capacity Simulator for Evaluating Measures to Reduce the Backlog of Hospital Services after the COVID-19 Pandemic

Autor: Bandeiras, C., Oliveira, F., Mota, M., Moita Fidalgo, R., Oliveira, A., Franco, C., Fernandes, C., Martins, I., Brito de Sá, M., Silva, J.P.

Publikováno v: In Value in Health December 2020 23 Supplement 2:S661-S662

PND37 Annual Cost of Acquisition of Disease Modifying Treatments in Treating ACTIVE Secondary Progressive Multiple Sclerosis Patients in Portugal

Autor: Silva, C., Bandeiras, C., Costa, A., Fernandes, P., Esparteiro, J.

Publikováno v: In Value in Health December 2020 23 Supplement 2:S629-S629